Charles Schwab Investment Management Inc Landec Corp \Ca\ Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 60,505 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,505
Previous 60,505
-0.0%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding LNDC
# of Institutions
80Shares Held
20.5MCall Options Held
65.8KPut Options Held
14.1K-
Wynnefield Capital Inc New York, NY4.92MShares$00.0% of portfolio
-
Legion Partners Asset Management, LLC Los Angeles, CA2.97MShares$00.0% of portfolio
-
Greenhaven Road Investment Management, L.P. Greenwich, CT2.23MShares$00.0% of portfolio
-
22 Nw, LP Seattle, WA1.76MShares$00.0% of portfolio
-
Black Rock Inc. New York, NY1.45MShares$00.0% of portfolio
About LANDEC CORP \CA\
- Ticker LNDC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 29,595,600
- Description
- Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...